Ypsomed Holding AG Company Description
Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for safe and simple self-medication companies.
The company operates through three segments: Ypsomed Delivery Systems, Ypsomed Diabetes Care, and Others.
The Ypsomed Delivery Systems segment provides various injection systems, such as pen injectors, auto-injectors, and wearable injectors, as well as other smart devices.
This segment offers its products under the YDS brand. The Ypsomed Diabetes Care segment sells and trades in insulin pumps, infusion sets, pen needles, blood glucose monitoring systems, accessories, and other day-to-day items for diabetics.
This segment offers its products under the mylife brand name. The company offers precision turned parts; and contract manufacturing and other services.
It markets its products through pharmaceutical partners, as well as through its own distribution network and independent distributors.
It operates in Switzerland, Europe, North America, and internationally. Ypsomed Holding AG was founded in 1984 and is headquartered in Burgdorf, Switzerland.

| Country | Switzerland |
| Founded | 1984 |
| Industry | Medical Instruments & Supplies |
| Sector | Healthcare |
| Employees | 2,025 |
| CEO | Simon Michel |
Contact Details
Address: Brunnmattstrasse 6 Burgdorf Switzerland | |
| Phone | 41 34 424 41 11 |
Stock Details
| Ticker Symbol | YPSN |
| Exchange | SIX Swiss Exchange |
| Fiscal Year | April - March |
| Reporting Currency | CHF |
| ISIN Number | CH0019396990 |
| SIC Code | 3842 |
Key Executives
| Name | Position |
|---|---|
| Frank Mengis | Chief Operating Officer, Deputy Chief Executive Officer Member of Executive Board |
| Simon Michel | Chief Executive Officer, Member of Executive Board and Member of the Board |
| Samuel Kunzli | Chief Financial Officer and Member of Executive Board |
| Ulrike Bauer | Chief Business Officer and Member of Executive Board |
| Michael Zaugg | Chief Corporate Officer and Member of Executive Board |
| Dr. Nicolas Meyer | Chief Legal Officer and Secretary and Member of Executive Board |
| Sam Ghezelbash | Head of Investor Relations and M&A |